This inventor holds 2 USPTO granted patents. Top assignee: Kaken Pharmaceutical Company, Ltd.. Active years: 2005.
Company Filing History:
Years Active: 2005
Title: Haruyoshi Ueo: Innovator in Cardiac and Neuroprotective Therapies
Introduction
Haruyoshi Ueo is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the fields of cardiac and neuroprotective therapies. With a focus on innovative solutions, Ueo has been instrumental in developing treatments that address critical health issues.
Latest Patents
Ueo holds 2 patents that showcase his expertise. His latest patents include a formulation for preventives or remedies for heart failure. This preparation is designed to prevent or treat acute heart failure, chronic heart failure during acute exacerbation, or heart failure transitioning to chronic stages. The active ingredient in this formulation is D-alanyl-3-(naphthalen-2-yl)-D-alanyl-L-alanyl-L-tryptophyl-D-phenylalanyl-L-lysinamide and/or its salts. Additionally, he has developed a neuroprotective drug aimed at preventing or treating diseases that involve degeneration or death of nerve cells. This agent is characterized by containing a growth hormone secretion promoting substance as an active ingredient.
Career Highlights
Ueo's career is marked by his dedication to advancing medical science. He has worked extensively in research and development, focusing on innovative therapies that can improve patient outcomes. His work has garnered attention in the medical community, highlighting the importance of his contributions.
Collaborations
Ueo collaborates with notable colleagues, including Takahiko Murata and Tadashi Ohyama. Their combined expertise enhances the research and development efforts at Kaken Pharmaceutical Company, Ltd., where Ueo is employed.
Conclusion
Haruyoshi Ueo is a distinguished inventor whose work in cardiac and neuroprotective therapies has the potential to make a significant impact on healthcare. His innovative patents reflect his commitment to improving patient care and advancing medical science.
